These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4625231)

  • 1. Serum inactivation of the immunological and biological activity of thyrotropin releasing hormone (TRH).
    Bassiri R; Utiger RD
    Endocrinology; 1972 Sep; 91(3):657-64. PubMed ID: 4625231
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the inactivation of thyrotropin-releasing hormone (TRH).
    Redding TW; Schally AV
    Proc Soc Exp Biol Med; 1969 Jun; 131(2):415-20. PubMed ID: 4977748
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyrotropin-releasing hormone secretory physiology: studies by radioimmunoassay and affinity chromatography.
    Montoya E; Seibel MJ; Wilber JF
    Endocrinology; 1975 Jun; 96(6):1413-8. PubMed ID: 805042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma thyrotropin (TSH) response to hypothalamic electrical stimulation and to injection of synthetic thyrotropin releasing hormone (TRH).
    Martin JB; Reichlin S
    Endocrinology; 1972 Apr; 90(4):1079-85. PubMed ID: 4622096
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analysis of time intervals in the actions of thyrotropin releasing hormone (TRH) in mice].
    Shishiba Y; Yoshimura S; Shimizu T; Shizume K
    Nihon Naibunpi Gakkai Zasshi; 1972 Jan; 47(10):654-7. PubMed ID: 4622090
    [No Abstract]   [Full Text] [Related]  

  • 6. Porcine thyrotropin releasing hormone is (pyro)glu-his-pro(NH2).
    Bowers CY; Schally AV; Enzmann F; Boler J; Folkers K
    Endocrinology; 1970 May; 86(5):1143-53. PubMed ID: 4985096
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological stability of calcitonin in plasma.
    Habener JF; Singer FR; Deftos LJ; Potts JT
    Endocrinology; 1972 Apr; 90(4):952-60. PubMed ID: 4622097
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of degradation and measurement of immunoreactive thyrotropin-releasing hormone in rat blood and plasma.
    Eskay RL; Oliver C; Warberg J; Porter JC
    Endocrinology; 1976 Feb; 98(2):269-77. PubMed ID: 813988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological action of synthetic hypothalamic hormone TRF (thyrortropin-releasing factor). 2. Specificity and modifying factor of synthetic of biological action of TRF].
    Sakoda M; Otsuki M; Kusaka T; Mori H; Mineyama T
    Nihon Naibunpi Gakkai Zasshi; 1970 Oct; 46(7):826-9. PubMed ID: 4991361
    [No Abstract]   [Full Text] [Related]  

  • 10. Different patterns of thyrotropin (TSH)-release, TSH-resynthesis and of corticosterone depression after in vivo administration of thyrotropin-releasing hormone (TRH) and of an isosteric analog of TRH.
    Steiner H; Piva F; Gavazzi G; Studer RO; Gillessen D; Martini L
    Horm Metab Res; 1972 Nov; 4(6):484-8. PubMed ID: 4632192
    [No Abstract]   [Full Text] [Related]  

  • 11. The physiological role of thyrotropin-releasing hormone in the regulation of thyroid-stimulating hormone and prolactin secretion in the rat.
    Harris AR; Christianson D; Smith MS; Fang SL; Braverman LE; Vagenakis AG
    J Clin Invest; 1978 Feb; 61(2):441-8. PubMed ID: 413840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thyrotropin-releasing factor (TRF)].
    Studer R; Werner I
    Schweiz Med Wochenschr; 1970 Jun; 100(25):1086-7. PubMed ID: 5004059
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans.
    Bassiri RM; Utiger RD
    J Clin Invest; 1973 Jul; 52(7):1616-9. PubMed ID: 4198107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A radioimmunoassay for the measurement of pyroglutamyl-histidyl-proline, a proposed thyrotropin releasing hormone metabolite.
    Visser TJ; Klootwijk W; Docter R; Hennemann G
    J Clin Endocrinol Metab; 1975 Apr; 40(4):742-5. PubMed ID: 805158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin releasing hormone (TRH) studies in patients with thyroid cancer.
    Samaan NA; Beceiro JR; Hill CS; Haynie TP; Glenn HJ
    J Clin Endocrinol Metab; 1972 Sep; 35(3):438-43. PubMed ID: 4626272
    [No Abstract]   [Full Text] [Related]  

  • 16. [TRH-progress in experimental and clinical studies].
    Sakota M
    Horumon To Rinsho; 1975 Jan; 23(1):7-15. PubMed ID: 168017
    [No Abstract]   [Full Text] [Related]  

  • 17. Site of inactivation of thyrotropin-releasing hormone by human plasma.
    Nair RM; Redding TW; Schally AV
    Biochemistry; 1971 Sep; 10(19):3621-4. PubMed ID: 5004409
    [No Abstract]   [Full Text] [Related]  

  • 18. Inactivation of the thyrotropin releasing hormone.
    Bauer K; Schulz M
    Acta Med Austriaca; 1992; 19 Suppl 1():79-82. PubMed ID: 1325726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition by somatostatin of the thyrotropin response to thyrotropin-releasing hormone in normal subjects.
    Weeke J; Hansen AP; Lundbaek K
    Scand J Clin Lab Invest; 1974 Apr; 33(2):101-3. PubMed ID: 4212424
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyroid hormones modulate thyrotropin-releasing hormone biosynthesis in tissues outside the hypothalamic-pituitary axis of male rats.
    Simard M; Pekary AE; Smith VP; Hershman JM
    Endocrinology; 1989 Jul; 125(1):524-31. PubMed ID: 2500333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.